Data collected from electronic health records, registries and wearable technology can be valuable sources of “real-world” data and evidence—just as valid as clinical trials—in helping the Food and Drug Administration to make regulatory decisions about the safety and effectiveness of medical devices.

That’s the contention of Health IT Now, a coalition of providers, patient advocates, consumers and payers, which provided written comments to the FDA regarding its draft guidance entitled Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices.

Register or login for access to this item and much more

All Information Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access